Nrx pharmaceuticals announces 2nd quarter 2021 financial update

Radnor, pa., aug. 16, 2021 /prnewswire/ -- nrx pharmaceuticals (nrx) (nasdaq: nrxp), a clinical stage biopharmaceutical company today provided a business update and financial results for the quarter ended june 30, 2021.
NRXP Ratings Summary
NRXP Quant Ranking